3rd Innovative Regulatory Pathways Summit 2020

  • Jan 2020
  • Arlington, VA, United States

Description

The 3rd Innovative Regulatory Pathways Summit 2020 covers topics such as:

  • The implications of breakthrough therapy designation, PRIME, and Sakigake Designation on development pipelines
  • The global regulatory landscape and effectively anticipate the future accelerated options
  • Regulatory strategies to optimize product development timelines
  • Leveraging the increased consideration that comes with utilizing an expedited development pathway
  • Best practices to liaise with the FDA, EMA, and PDMA about expedited regulatory approvals

The 3rd Innovative Regulatory Pathways Summit 2020 brings together representatives from pharmaceutical, biotechnology, and medical device companies with responsibilities in:

  • Business Development/Strategy
  • Regulatory Affairs/Strategy/Operations
  • Product Development
  • Clinical Operations/Development/Affairs
  • Patient Advocacy
  • R&D/Drug Development
  • Strategic Planning
  • HEOR and Outcomes Research
  • Oncology Program Management
  • Competitive Intelligence
  • Pipeline/Portfolio Management
  • Rare Disease/Orphan Program Management
  • Medical Information/Affairs
  • Pharmacovigilance

Also:

  • Clinical/Contract Research Organizations
  • Regulatory Advisors/Service Providers/Consultants
  • Law Firms
  • Drug Development Service Providers
  • Strategic/Management Consultants
  • Preclinical/Analytical Research Organizations

Past Events

Important

Please, check "Innovative Regulatory Pathways Summit" official website for possible changes, before making any traveling arrangements

Event Categories

Government & Global Issues: Law & Regulations
Health & Medicine: Healthcare

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions